Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service

BACKGROUND: There is a controversy whether it is safe to continue renin-angiotensin system blockers in patients with coronavirus disease 2019 (COVID-19). We analyzed big data to investigate whether angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers have any significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jaiyong, Kim, Dong Wook, Kim, Kwang-il, Kim, Hong Bin, Kim, Jong-Hun, Lee, Yong-Gab, Byeon, Kyeong Hyang, Cheong, Hae-Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324263/
https://www.ncbi.nlm.nih.gov/pubmed/32597045
http://dx.doi.org/10.3346/jkms.2020.35.e232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324263/
https://www.ncbi.nlm.nih.gov/pubmed/32597045
http://dx.doi.org/10.3346/jkms.2020.35.e232

Ejemplares similares